From: The safety of antithrombotic therapy in patients with cerebral microbleeds and cardiogenic cerebral embolism due to nonvalvular atrial fibrillation
CMBs group n = 110
non-CMBs group n = 122
t or χ2
P value
Event-free time (months)
21.4 ± 12.7
23.4 ± 14.0
−1.101
0.272
CH events (%)
18 (16.4)
13 (10.7)
1.628
0.202
All-cause death (%)
14 (12.7)
0.241
0.623